The influence of sex-linked genetic mechanisms on attention and impulsivity

Biological Psychology

Volumn 89, Issue 1, 2012, Pages 1-13

  Trent, Simon ^a   Davies, William ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Attention; Attention deficit hyperactivity disorder; Autism; COMT; Impulsivity; MAOA; Neuropsychiatric disorders; Neurosteroids; Sex chromosomes; Sexual dimorphism; SRY; Steroid sulfatase; Turner syndrome

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A;

ADDICTION; ATTENTION; ATTENTION DEFICIT DISORDER; AUTISM; AUTOSOME; CHROMOSOME ABERRATION; GENE; GENE DOSAGE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; IMPULSIVENESS; MAOA GENE; MENTAL DISEASE; NEUROANATOMY; NEUROCHEMISTRY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SEX DIFFERENTIATION; SINGLE NUCLEOTIDE POLYMORPHISM; SRY GENE; STS GENE; SYMPTOMATOLOGY;

ATTENTION; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MENTAL DISORDERS; MONOAMINE OXIDASE; SEX CHARACTERISTICS; SEX-DETERMINING REGION Y PROTEIN; STERYL-SULFATASE;

EID: 84155166968     PISSN: 03010511     EISSN: 18736246     Source Type: Journal    
DOI: 10.1016/j.biopsycho.2011.09.011     Document Type: Review

References (261)

1. Abrahams B.S., Geschwind D.H. Advances in autism genetics: on the threshold of a new neurobiology. Nature Reviews Genetics 2008, 9:341-355.
2. Adler L.A., Faraone S.V., Spencer T.J., Michelson D., Reimherr F.W., Glatt S.J., et al. The reliability and validity of self- and investigator ratings of ADHD in adults. Journal of Attention Disorders 2008, 11:711-719.
3. Alessi S.M., Petry N.M. Pathological gambling severity is associated with impulsivity in a delay discounting procedure. Behavioural Processes 2003, 64:345-354.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Press, Washington, DC.
5. Andersen S.L., Teicher M.H. Sex differences in dopamine receptors and their relevance to ADHD. Neuroscience and Biobehavioral Reviews 2000, 24:137-141.
6. Anker J.J., Gliddon L.A., Carroll M.E. Impulsivity on a Go/No-go task for intravenous cocaine or food in male and female rats selectively bred for high and low saccharin intake. Behavioural Pharmacology 2008, 19:615-629.
7. Arnold A.P., Chen X. What does the "four core genotypes" mouse model tell us about sex differences in the brain and other tissues?. Frontiers in Neuroendocrinology 2009, 30:1-9.
8. Aron A.R., Fletcher P.C., Bullmore E.T., Sahakian B.J., Robbins T.W. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nature Neuroscience 2003, 6:115-116.
9. Bach A.W., Lan N.C., Johnson D.L., Abell C.W., Bembenek M.E., Kwan S.W., et al. cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proceedings of the National Academy of Sciences of the United States of America 1988, 85:4934-4938.
10. Bailey A., Le Couteur A., Gottesman I., Bolton P., Simonoff E., Yuzda E., Rutter M. Autism as a strongly genetic disorder: evidence from a British twin study. Psychological Medicine 1995, 25:63-77.
11. Band G.P., van Boxtel G.J. Inhibitory motor control in stop paradigms: review and reinterpretation of neural mechanisms. Acta Psychologica 1999, 101:179-211.
12. Baron-Cohen S. The extreme male brain theory of autism. Trends in Cognitive Sciences 2002, 6:248-254.
13. Baron-Cohen S., Knickmeyer R.C., Belmonte M.K. Sex differences in the brain: implications for explaining autism. Science 2005, 310:819-823.
14. Beane M., Marrocco R.T. Norepinephrine and acetylcholine mediation of the components of reflexive attention: implications for attention deficit disorders. Progress in Neurobiology 2004, 74:167-181.
15. Bechara A., Damasio A.R., Damasio H., Anderson S.W. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994, 50:7-15.
16. Becker J.B., Hu M. Sex differences in drug abuse. Frontiers in Neuroendocrinology 2008, 29:36-47.
17. Belelli D., Lambert J.J. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nature Reviews Neuroscience 2005, 6:565-575.
18. Berta P., Hawkins J.R., Sinclair A.H., Taylor A., Griffiths B.L., Goodfellow P.N., Fellous M. Genetic evidence equating SRY and the testis-determining factor. Nature 1990, 348:448-450.
19. Biederman J., Kim J.W., Doyle A.E., Mick E., Fagerness J., Smoller J.W., Faraone S.V. Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study. American Journal of Medical Genetics, Part B Neuropsychiatric Genetics 2008, 147B:1511-1518.
20. Biederman J., Mick E., Faraone S.V., Braaten E., Doyle A., Spencer T., et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. American Journal of Psychiatry 2002, 159:36-42.
21. Bjork J.M., Moeller F.G., Dougherty D.M., Swann A.C. Endogenous plasma testosterone levels and commission errors in women: a preliminary report. Physiology and Behavior 2001, 73:217-221.
22. Bland S.T., Schmid M.J., Der-Avakian A., Watkins L.R., Spencer R.L., Maier S.F. Expression of c-fos and BDNF mRNA in subregions of the prefrontal cortex of male and female rats after acute uncontrollable stress. Brain Research 2005, 1051:90-99.
23. Blaszczynski A., Steel Z., McConaghy N. Impulsivity in pathological gambling: the antisocial impulsivist. Addiction 1997, 92:75-87.
24. Bloss C.S., Courchesne E. MRI neuroanatomy in young girls with autism: a preliminary study. Journal of the American Academy of Child and Adolescent Psychiatry 2007, 46:515-523.
25. Bolla K.I., Eldreth D.A., Matochik J.A., Cadet J.L. Sex-related differences in a gambling task and its neurological correlates. Cerebral Cortex 2004, 14:1226-1232.
26. Bortolato M., Chen K., Shih J.C. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Advanced Drug Delivery Reviews 2008, 60:1527-1533.
27. Botvinick M.M., Cohen J.D., Carter C.S. Conflict monitoring and anterior cingulate cortex: an update. Trends in Cognitive Sciences 2004, 8:539-546.
28. Boulougouris V., Tsaltas E. Serotonergic and dopaminergic modulation of attentional processes. Progress in Brain Research 2008, 172:517-542.
29. Brady K.T., Randall C.L. Gender differences in substance use disorders. Pediatric Clinics of North America 1999, 22:241-252.
30. Brass M., von Cramon D.Y. The role of the frontal cortex in task preparation. Cerebral Cortex 2002, 12:908-914.
31. Breese G.R., Chu K., Dayas C.V., Funk D., Knapp D.J., Koob G.F., et al. Stress enhancement of craving during sobriety: a risk for relapse. Alcoholism, Clinical and Experimental Research 2005, 29:185-195.
32. Brookes K.J., Hawi Z., Kirley A., Barry E., Gill M., Kent L. Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder. American Journal of Medical Genetics, Part B Neuropsychiatric Genetics 2008, 147B:1531-1535.
33. Brookes K.J., Hawi Z., Park J., Scott S., Gill M., Kent L. Polymorphisms of the steroid sulfatase (STS) gene are associated with attention deficit hyperactivity disorder and influence brain tissue mRNA expression. American Journal of Medical Genetics, Part B Neuropsychiatric Genetics 2010, 153B:1417-1424.
34. Brunner H.G., Nelen M., Breakefield X.O., Ropers H.H., van Oost B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993, 262:578-580.
35. Bush G. Attention-deficit/hyperactivity disorder and attention networks. Neuropsychopharmacology 2010, 35:278-300.
36. Bush G., Luu P., Posner M.I. Cognitive and emotional influences in anterior cingulate cortex. Trends in Cognitive Sciences 2000, 4:215-222.
37. Cahill L. Why sex matters for neuroscience. Nature Reviews Neuroscience 2006, 7:477-484.
38. Cardinal R.N. Neural systems implicated in delayed and probabilistic reinforcement. Neural Network 2006, 19:1277-1301.
39. Cardinal R.N., Pennicott D.R., Sugathapala C.L., Robbins T.W., Everitt B.J. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 2001, 292:2499-2501.
40. Cardinal R.N., Winstanley C.A., Robbins T.W., Everitt B.J. Limbic corticostriatal systems and delayed reinforcement. Annals of the New York Academy of Sciences 2004, 1021:33-50.
41. Carpenter M.J., Upadhyaya H.P., LaRowe S.D., Saladin M.E., Brady K.T. Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review. Nicotine and Tobacco Research 2006, 8:627-638.
42. Carpenter Rich E., Loo S.K., Yang M., Dang J., Smalley S.L. Social functioning difficulties in ADHD: association with PDD risk. Clinical Child Psychology and Psychiatry 2009, 14:329-344.
43. Carrell L., Willbard H. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005, 434:400-404.
44. Carroll M.E., Lynch W.J., Roth M.E., Morgan A.D., Cosgrove K.P. Sex and estrogen influence drug abuse. Trends in Pharmacological Sciences 2004, 25:273-279.
45. Cases O., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S., et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 1995, 268:1763-1766.
46. Castellanos F.X., Giedd J.N., Berquin P.C., Walter J.M., Sharp W., Tran T., et al. Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Archives of General Psychiatry 2001, 58:289-295.
47. Chamberlain S.R., Muller U., Blackwell A.D., Clark L., Robbins T.W., Sahakian B.J. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science 2006, 311:861-863.
48. Chen J., Lipska B.K., Halim N., Ma Q.D., Matsumoto M., Melhem S., et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. American Journal of Human Genetics 2004, 75:807-821.
49. Chen W.J., Faraone S.V. Sustained attention deficits as markers of genetic susceptibility to schizophrenia. American Journal of Medical Genetics 2000, 97:52-57.
50. Cherrier M.M., Anawalt B.D., Herbst K.L., Amory J.K., Craft S., Matsumoto A.M., Bremner W.J. Cognitive effects of short-term manipulation of serum sex steroids in healthy young men. Journal of Clinical Endocrinology and Metabolism 2002, 87:3090-3096.
51. Christakou A., Robbins T.W., Everitt B.J. Prefrontal cortical-ventral striatal interactions involved in affective modulation of attentional performance: implications for corticostriatal circuit function. Journal of Neuroscience 2004, 24:773-780.
52. Cole B.J., Robbins T.W. Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic-noradrenergic interactions. Psychopharmacology (Berlin) 1987, 91:458-466.
53. Corbetta M. Frontoparietal cortical networks for directing attention and the eye to visual locations: identical, independent, or overlapping neural systems?. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:831-838.
54. Corbetta M., Kincade J.M., Ollinger J.M., McAvoy M.P., Shulman G.L. Voluntary orienting is dissociated from target detection in human posterior parietal cortex. Nature Neuroscience 2000, 3:292-297.
55. Cornforth C., Sonuga-Barke E., Coghill D. Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients. Current Pharmaceutical Design 2010, 16:2424-2433.
56. Coull J.T., Frith C.D., Frackowiak R.S., Grasby P.M. A fronto-parietal network for rapid visual information processing: a PET study of sustained attention and working memory. Neuropsychologia 1996, 34:1085-1095.
57. Craft R.M. Sex differences in opioid analgesia: "from mouse to man" Clinical Journal of Pain 2003, 19:175-186.
58. Crean J., Richards J.B., de Wit H. Effect of tryptophan depletion on impulsive behavior in men with or without a family history of alcoholism. Behavioural Brain Research 2002, 136:349-357.
59. Cuevas-Covarrubias S.A., Juarez-Oropeza M.A., Miranda-Zamora R., Diaz-Zagoya J.C. Comparative analysis of human steroid sulfatase activity in prepubertal and postpubertal males and females. Biochemistry and Molecular Biology International 1993, 30:691-695.
60. Dalley J.W., Mar A.C., Economidou D., Robbins T.W. Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacology Biochemistry and Behavior 2008, 90:250-260.
61. Davies W., Humby T., Isles A.R., Burgoyne P.S., Wilkinson L.S. X-monosomy effects on visuospatial attention in mice: a candidate gene and implications for Turner syndrome and attention deficit hyperactivity disorder. Biological Psychiatry 2007, 61:1351-1360.
62. Davies W., Humby T., Kong W., Otter T., Burgoyne P.S., Wilkinson L.S. Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention. Biological Psychiatry 2009, 66:360-367.
63. Davies W., Isles A.R., Wilkinson L.S. Imprinted gene expression in the brain. Neuroscience and Biobehavioral Reviews 2005, 29:421-430.
64. Davies W., Wilkinson L.S. It is not all hormones: alternative explanations for sexual differentiation of the brain. Brain Research 2006, 1126:36-45.
65. de Bruin E.I., Verheij F., Wiegman T., Ferdinand R.F. Differences in finger length ratio between males with autism, pervasive developmental disorder-not otherwise specified, ADHD, and anxiety disorders. Developmental Medicine and Child Neurology 2006, 48:962-965.
66. De Vries G.J., Rissman E.F., Simerly R.B., Yang L.Y., Scordalakes E.M., Auger C.J., et al. A model system for study of sex chromosome effects on sexually dimorphic neural and behavioral traits. Journal of Neuroscience 2002, 22:9005-9014.
67. de Wit H., Crean J., Richards J.B. Effects of d-amphetamine and ethanol on a measure of behavioral inhibition in humans. Behavioral Neuroscience 2000, 114:830-837.
68. de Wit H., Enggasser J.L., Richards J.B. Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 2002, 27:813-825.
69. Derevensky J.L., Pratt L.M., Hardoon K.K., Gupta R. Gambling problems and features of attention deficit hyperactivity disorder among children and adolescents. Journal of Addictive Medicines 2007, 1:165-172.
70. Derks E.M., Hudziak J.J., Boomsma D.I. Why more boys than girls with ADHD receive treatment: a study of Dutch twins. Twin Research and Human Genetics 2007, 10:765-770.
71. Dewing P., Chiang C.W., Sinchak K., Sim H., Fernagut P.O., Kelly S., et al. Direct regulation of adult brain function by the male-specific factor SRY. Current Biology 2006, 16:415-420.
72. Dewing P., Shi T., Horvath S., Vilain E. Sexually dimorphic gene expression in mouse brain precedes gonadal differentiation. Brain Research: Molecular Brain Research 2003, 118:82-90.
73. Dove A., Pollmann S., Schubert T., Wiggins C.J., von Cramon D.Y. Prefrontal cortex activation in task switching: an event-related fMRI study. Brain Research: Cognitive Brain Research 2000, 9:103-109.
74. Dubrovsky B.O. Steroids, neuroactive steroids and neurosteroids in psychopathology. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2005, 29:169-192.
75. Duff S.J., Hampson E. A sex difference on a novel spatial working memory task in humans. Brain and Cognition 2001, 47:470-493.
76. Eagle D.M., Baunez C. Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition. Neuroscience and Biobehavioral Reviews 2010, 34:50-72.
77. Eagle D.M., Robbins T.W. Inhibitory control in rats performing a stop-signal reaction-time task: effects of lesions of the medial striatum and d-amphetamine. Behavioral Neuroscience 2003, 117:1302-1317.
78. Elkins I.J., McGue M., Iacono W.G. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Archives of General Psychiatry 2007, 64:1145-1152.
79. Eskiw C.H., Cope N.F., Clay I., Schoenfelder S., Nagano T., Fraser P. Transcription factories and nuclear organization of the genome. Cold Spring Harbour Symposia on Quantitative Biology 2010, 75:501-506.
80. Evenden J. Impulsivity: a discussion of clinical and experimental findings. Journal of Psychopharmacology 1999, 13:180-192.
81. Evenden J.L. Varieties of impulsivity. Psychopharmacology (Berlin) 1999, 146:348-361.
82. Fan J., Flombaum J.I., McCandliss B.D., Thomas K.M., Posner M.I. Cognitive and brain consequences of conflict. Neuroimage 2003, 18:42-57.
83. Fan J., Fossella J., Sommer T., Wu Y., Posner M.I. Mapping the genetic variation of executive attention onto brain activity. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:7406-7411.
84. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biological Psychiatry 2005, 57:1313-1323.
85. Feola T.W., de Wit H., Richards J.B. Effects of d-amphetamine and alcohol on a measure of behavioral inhibition in rats. Behavioral Neuroscience 2000, 114:838-848.
86. Folstein S., Rutter M. Genetic influences and infantile autism. Nature 1977, 265:726-728.
87. Fombonne E. Epidemiological trends in rates of autism. Molecular Psychiatry 2002, 7(Suppl. 2):S4-S6.
88. Fossella J., Sommer T., Fan J., Wu Y., Swanson J.M., Pfaff D.W., Posner M.I. Assessing the molecular genetics of attention networks. BMC Neuroscience 2002, 3:14.
89. Friedrich F.J., Egly R., Rafal R.D., Beck D. Spatial attention deficits in humans: a comparison of superior parietal and temporal-parietal junction lesions. Neuropsychology 1998, 12:193-207.
90. Galanopoulou A.S. GABA receptors as broadcasters of sexually differentiating signals in the brain. Epilepsia 2005, 46(Suppl. 5):107-112.
91. Gershon J. A meta-analytic review of gender differences in ADHD. Journal of Attention Disorders 2002, 5:143-154.
92. Gizer I.R., Ficks C., Waldman I.D. Candidate gene studies of ADHD: a meta-analytic review. Human Genetics 2009, 126:51-90.
93. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., Karayiorgou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:9991-9996.
94. Goldman P.S., Crawford H.T., Stokes L.P., Galkin T.W., Rosvold H.E. Sex-dependent behavioral effects of cerebral cortical lesions in the developing rhesus monkey. Science 1974, 186:540-542.
95. Goldstein J.M., Seidman L.J., Horton N.J., Makris N., Kennedy D.N., Caviness V.S., et al. Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cerebral Cortex 2001, 11:490-497.
96. Gravholt C.H. Epidemiological, endocrine and metabolic features in Turner syndrome. European Journal of Endocrinology/European Federation of Endocrine Societies 2004, 151:657-687.
97. Greven C.U., Rijsdijk F.V., Plomin R. A twin study of ADHD symptoms in early adolescence: hyperactivity-impulsivity and inattentiveness show substantial genetic overlap but also genetic specificity. Journal of Abnormal Child Psychology 2011, 39:265-275.
98. Gunther T., Herpertz-Dahlmann B., Konrad K. Sex differences in attentional performance and their modulation by methylphenidate in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 2010, 20:179-186.
99. Hamann S. Sex differences in the responses of the human amygdala. Neuroscientist 2005, 11:288-293.
100. Harrison A.A., Everitt B.J., Robbins T.W. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology (Berlin) 1997, 133:329-342.
101. Harrison A.A., Everitt B.J., Robbins T.W. Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination. Behavioural Brain Research 1999, 100:99-112.
102. Hattori J., Ogino T., Abiru K., Nakano K., Oka M., Ohtsuka Y. Are pervasive developmental disorders and attention-deficit/hyperactivity disorder distinct disorders?. Brain and Development 2006, 28:371-374.
103. Heal D.J., Cheetham S.C., Smith S.L. The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology 2009, 57:608-618.
104. Heard E., Bickmore W. The ins and outs of gene regulation and chromosome territory organisation. Current Opinion in Cell Biology 2007, 19:311-316.
105. Hernandez-Avila C.A., Rounsaville B.J., Kranzler H.R. Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug and Alcohol Dependence 2004, 74:265-272.
106. Higgins G.A., Ballard T.M., Huwyler J., Kemp J.A., Gill R. Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition. Neuropharmacology 2003, 44:324-341.
107. Hill D.E., Yeo R.A., Campbell R.A., Hart B., Vigil J., Brooks W. Magnetic resonance imaging correlates of attention-deficit/hyperactivity disorder in children. Neuropsychology 2003, 17:496-506.
108. Holden C. Sex and the suffering brain. Science 2005, 308:1574.
109. Holtmann M., Bolte S., Poustka F. Autism spectrum disorders: sex differences in autistic behaviour domains and coexisting psychopathology. Developmental Medicine & Child Neurology 2007, 49:361-366.
110. Huster R.J., Westerhausen R., Herrmann C.S. Sex differences in cognitive control are associated with midcingulate and callosal morphology. Brain Structure and Function 2011, 215:225-235.
111. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annual Review of Neuroscience 2006, 29:565-598.
112. Isles A.R., Humby T., Wilkinson L.S. Measuring impulsivity in mice using a novel operant delayed reinforcement task: effects of behavioural manipulations and d-amphetamine. Psychopharmacology (Berlin) 2003, 170:376-382.
113. Jazin E., Cahill L. Sex differences in molecular neuroscience: from fruit flies to humans. Nature Reviews Neuroscience 2010, 11:9-17.
114. Johansson A., Grant J.E., Kim S.W., Odlaug B.L., Gotestam K.G. Risk factors for problematic gambling: a critical literature review. Journal of Gambling Studies 2009, 25:67-92.
115. Karnath H.O., Ferber S., Himmelbach M. Spatial awareness is a function of the temporal not the posterior parietal lobe. Nature 2001, 411:950-953.
116. Kashimada K., Koopman P. Sry: the master switch in mammalian sex determination. Development 2010, 137:3921-3930.
117. Kent L., Emerton J., Bhadravathi V., Weisblatt E., Pasco G., Willatt L.R., et al. X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits. Journal of Medical Genetics 2008, 45:519-524.
118. Kinnally E.L., Huang Y.Y., Haverly R., Burke A.K., Galfalvy H., Brent D.P., et al. Parental care moderates the influence of MAOA-uVNTR genotype and childhood stressors on trait impulsivity and aggression in adult women. Psychiatric Genetics 2009, 19:126-133.
119. Kirby K.N., Petry N.M., Bickel W.K. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. Journal of Experimental Psychology: General 1999, 128:78-87.
120. Klein L.C., Corwin E.J. Seeing the unexpected: how sex differences in stress responses may provide a new perspective on the manifestation of psychiatric disorders. Current Psychiatry Reports 2002, 4:441-448.
121. Klein M., Ponds R.W., Houx P.J., Jolles J. Effect of test duration on age-related differences in Stroop interference. Journal of Clinical and Experimental Neuropsychology 1997, 19:77-82.
122. Kopsida E., Stergiakouli E., Lynn P.M., Wilkinson L.S., Davies W. The role of the Y chromosome in brain function. Open Neuroendocrinology Journal 2009, 2:20-30.
123. Kriz L., Bicikova M., Hill M., Hampl R. Steroid sulfatase and sulfuryl transferase activity in monkey brain tissue. Steroids 2005, 70:960-969.
124. Kuntsi J., Rijsdijk F., Ronald A., Asherson P., Plomin R. Genetic influences on the stability of attention-deficit/hyperactivity disorder symptoms from early to middle childhood. Biological Psychiatry 2005, 57:647-654.
125. Lahey B.B., Applegate B., McBurnett K., Biederman J., Greenhill L., Hynd G.W., et al. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. American Journal of Psychiatry 1994, 151:1673-1685.
126. Lahr G., Maxson S.C., Mayer A., Just W., Pilgrim C., Reisert I. Transcription of the Y chromosomal gene, Sry, in adult mouse brain. Brain Research: Molecular Brain Research 1995, 33:179-182.
127. Lan N.C., Heinzmann C., Gal A., Klisak I., Orth U., Lai E., et al. Human monoamine oxidase A and B genes map to Xp 11.23 and are deleted in a patient with Norrie disease. Genomics 1989, 4:552-559.
128. Lanfranco F., Kamischke A., Zitzmann M., Nieschlag E. Klinefelter's syndrome. Lancet 2004, 364:273-283.
129. Larsson H., Lichtenstein P., Larsson J.O. Genetic contributions to the development of ADHD subtypes from childhood to adolescence. Journal of the American Academy of Child and Adolescent Psychiatry 2006, 45:973-981.
130. Le Moal M., Koob G.F. Drug addiction: pathways to the disease and pathophysiological perspectives. European Neuropsychopharmacology 2007, 17:377-393.
131. Lee D.O., Ousley O.Y. Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology 2006, 16:737-746.
132. Leggett V., Jacobs P., Nation K., Scerif G., Bishop D.V. Neurocognitive outcomes of individuals with a sex chromosome trisomy: XXX, XYY, or XXY: a systematic review. Developmental Medicine and Child Neurology 2010, 52:119-129.
133. Lejuez C.W., Bornovalova M.A., Reynolds E.K., Daughters S.B., Curtin J.J. Risk factors in the relationship between gender and crack/cocaine. Experimental and Clinical Psychopharmacology 2007, 15:165-175.
134. Lemon J.M., Gargaro B., Enticott P.G., Rinehart N.J. Executive functioning in autism spectrum disorders: a gender comparison of response inhibition. Journal of Autism and Developmental Disorders 2011, 41:352-356.
135. Li C.S., Huang C., Constable R.T., Sinha R. Gender differences in the neural correlates of response inhibition during a stop signal task. Neuroimage 2006, 32:1918-1929.
136. Li J., Wang Y., Hu S., Zhou R., Yu X., Wang B., et al. The monoamine oxidase B gene exhibits significant association to ADHD. American Journal of Medical Genetics, Part B Neuropsychiatric Genetics 2008, 147:370-374.
137. Linden M.G., Bender B.G. Fifty-one prenatally diagnosed children and adolescents with sex chromosome abnormalities. American Journal of Medical Genetics 2002, 110:11-18.
138. Lipszyc J., Schachar R. Inhibitory control and psychopathology: a meta-analysis of studies using the stop signal task. Journal of the International Neuropsychological Society 2010, 16:1064-1076.
139. Liu X., Banich M.T., Jacobson B.L., Tanabe J.L. Common and distinct neural substrates of attentional control in an integrated Simon and spatial Stroop task as assessed by event-related fMRI. Neuroimage 2004, 22:1097-1106.
140. Lord C., Leventhal B.L., Cook E.H. Quantifying the phenotype in autism spectrum disorders. American Journal of Medical Genetics 2001, 105:36-38.
141. Lynch W.J., Roth M.E., Carroll M.E. Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology (Berlin) 2002, 164:121-137.
142. Lynn P.M., Davies W. The 39,XO mouse as a model for the neurobiology of Turner syndrome and sex-biased neuropsychiatric disorders. Behavioural Brain Research 2007, 179:173-182.
143. Maayan R., Yoran-Hegesh R., Strous R., Nechmad A., Averbuch E., Weizman A., Spivak B. Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder. Neuropsychobiology 2003, 48:111-115.
144. Madden G.J., Petry N.M., Badger G.J., Bickel W.K. Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards. Experimental and Clinical Psychopharmacology 1997, 5:256-262.
145. Madeira M.D., Lieberman A.R. Sexual dimorphism in the mammalian limbic system. Progress in Neurobiology 1995, 45:275-333.
146. Mann K., Ackermann K., Croissant B., Mundle G., Nakovics H., Diehl A. Neuroimaging of gender differences in alcohol dependence: are women more vulnerable?. Alcoholism, Clinical and Experimental Research 2005, 29:896-901.
147. Manuck S.B., Flory J.D., Ferrell R.E., Mann J.J., Muldoon M.F. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Research 2000, 95:9-23.
148. Marchant B.K., Reimherr F.W., Halls C., Williams E.D., Strong R.E., Kondo D., et al. Long-term open-label response to atomoxetine in adult ADHD: influence of sex, emotional dysregulation, and double-blind response to atomoxetine. Attention Deficit Hyperactivity Disorder 2011, 3:237-244.
149. Marrocco R.T., Davidson M.C. Neurochemistry of attention. The Attentional Brain 1998, 35-50. R. Parasuraman (Ed.).
150. Marrocco R.T., Witte E.A., Davidson M.C. Arousal systems. Current Opinion in Neurobiology 1994, 4:166-170.
151. Martel M.M., Klump K., Nigg J.T., Breedlove S.M., Sisk C.L. Potential hormonal mechanisms of attention-deficit/hyperactivity disorder and major depressive disorder: a new perspective. Hormones and Behavior 2009, 55:465-479.
152. Martins S.S., Lobo D.S., Tavares H., Gentil V. Pathological gambling in women: a review. Revista do Hospital Das Clinicas; Faculdade de Medicina da Universidade de Sao Paulo 2002, 57:235-242.
153. Martins S.S., Storr C.L., Ialongo N.S., Chilcoat H.D. Gender differences in mental health characteristics and gambling among African-American adolescent gamblers. American Journal on Addictions 2008, 17:126-134.
154. Mayer A., Lahr G., Swaab D.F., Pilgrim C., Reisert I. The Y-chromosomal genes SRY and ZFY are transcribed in adult human brain. Neurogenetics 1998, 1:281-288.
155. Mechelli A., Friston K.J., Frackowiak R.S., Price C.J. Structural covariance in the human cortex. Journal of Neuroscience 2005, 25:8303-8310.
156. Mecklinger A.D., von Cramon D.Y., Springer A., Matthes-von Cramon G. Executive control functions in task switching: evidence from brain injured patients. Journal of Clinical and Experimental Neuropsychology 1999, 21:606-619.
157. Milham M.P., Banich M.T., Webb A., Barad V., Cohen N.J., Wszalek T., Kramer A.F. The relative involvement of anterior cingulate and prefrontal cortex in attentional control depends on nature of conflict. Brain Research: Cognitive Brain Research 2001, 12:467-473.
158. Milsted A., Serova L., Sabban E.L., Dunphy G., Turner M.E., Ely D.L. Regulation of tyrosine hydroxylase gene transcription by Sry. Neuroscience Letters 2004, 369:203-207.
159. Moeller F.G., Barratt E.S., Dougherty D.M., Schmitz J.M., Swann A.C. Psychiatric aspects of impulsivity. American Journal of Psychiatry 2001, 158:1783-1793.
160. Moering R.G., Schinka J.A., Mortimer J.A., Graves A.B. Normative data for elderly African Americans for the Stroop color and word test. Archives of Clinical Neuropsychology 2004, 19:61-71.
161. Moreno M., Cardona D., Gomez M.J., Sanchez-Santed F., Tobena A., Fernandez-Teruel A., et al. Impulsivity characterization in the Roman high- and low-avoidance rat strains: behavioral and neurochemical differences. Neuropsychopharmacology 2010, 35:1198-1208.
162. Moritz S., Birkner C., Kloss M., Jahn H., Hand I., Haasen C., Krausz M. Executive functioning in obsessive-compulsive disorder, unipolar depression, and schizophrenia. Archives of Clinical Neuropsychology 2002, 17:477-483.
163. Mulligan A., Gill M., Fitzgerald M. A case of ADHD and a major Y chromosome abnormality. Journal of Attention Disorders 2008, 12:103-105.
164. Nicolas L.B., Pinoteau W., Papot S., Routier S., Guillaumet G., Mortaud S. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice. Brain Research 2001, 922:216-222.
165. Nieoullon A. Dopamine and the regulation of cognition and attention. Progress in Neurobiology 2002, 67:53-83.
166. Nijhuis-van der Sanden M.W., Eling P.A., Otten B.J. A review of neuropsychological and motor studies in Turner Syndrome. Neuroscience and Biobehavioral Reviews 2003, 27:329-338.
167. Nikolas M.A., Burt S.A. Genetic and environmental influences on ADHD symptom dimensions of inattention and hyperactivity: a meta-analysis. Journal of Abnormal Psychology 2010, 119:1-17.
168. Nishizawa S., Benkelfat C., Young S.N., Leyton M., Mzengeza S., de Montigny C., et al. Differences between males and females in rates of serotonin synthesis in human brain. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:5308-5313.
169. Ohno S., Kaplan W.D., Kinosita R. Formation of the sex chromatin by a single X-chromosome in liver cells of Rattus norvegicus. Experimental Cell Research 1959, 18:415-418.
170. Oreland L., Damberg M., Hallman J., Berggard C., Garpenstrand H. Risk factors for the neurohumoral alterations underlying personality disturbances. Neurotoxicity Research 2002, 4:421-426.
171. Overman W.H. Sex differences in early childhood, adolescence, and adulthood on cognitive tasks that rely on orbital prefrontal cortex. Brain and Cognition 2004, 55:134-147.
172. Parasuraman R., Greenwood P.M., Haxby J.V., Grady C.L. Visuospatial attention in dementia of the Alzheimer type. Brain 1992, 115(Pt. 3):711-733.
173. Pastor P.N., Reuben C.A. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006. Vital and Health Statistics 2008, 10:1-14.
174. Pattij T., Vanderschuren L.J. The neuropharmacology of impulsive behaviour. Trends in Pharmacological Sciences 2008, 29:192-199.
175. Perry J.L., Carroll M.E. The role of impulsive behavior in drug abuse. Psychopharmacology (Berlin) 2008, 200:1-26.
176. Perry J.L., Nelson S.E., Anderson M.M., Morgan A.D., Carroll M.E. Impulsivity (delay discounting) for food and cocaine in male and female rats selectively bred for high and low saccharin intake. Pharmacology Biochemistry and Behavior 2007, 86:822-837.
177. Petry N.M. Substance abuse, pathological gambling, and impulsiveness. Drug and Alcohol Dependence 2001, 63:29-38.
178. Petry N.M., Casarella T. Excessive discounting of delayed rewards in substance abusers with gambling problems. Drug and Alcohol Dependence 1999, 56:25-32.
179. Polanczyk G., de Lima M.S., Horta B.L., Biederman J., Rohde L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. American Journal of Psychiatry 2007, 164:942-948.
180. Posner M.I., Petersen S.E. The attention system of the human brain. Annual Review of Neuroscience 1990, 13:25-42.
181. Qian Q., Wang Y., Zhou R., Li J., Wang B., Glatt S., Faraone S.V. Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. American Journal of Medical Genetics, Part B Neuropsychiatric Genetics 2003, 118B:103-109.
182. Quinn J.J., Hitchcott P.K., Umeda E.A., Arnold A.P., Taylor J.R. Sex chromosome complement regulates habit formation. Nature Neuroscience 2007, 10:1398-1400.
183. Raz A. Anatomy of attentional networks. Anatomical Record. Part B, New Anatomist 2004, 281:21-36.
184. Raz A., Buhle J. Typologies of attentional networks. Nature Reviews Neuroscience 2006, 7:367-379.
185. Reavis R., Overman W.H. Adult sex differences on a decision-making task previously shown to depend on the orbital prefrontal cortex. Behavioral Neuroscience 2001, 115:196-206.
186. Reed M.J., Purohit A., Woo L.W., Newman S.P., Potter B.V. Steroid sulfatase: molecular biology, regulation, and inhibition. Endocrine Reviews 2005, 26:171-202.
187. Reik W., Lewis A. Co-evolution of X-chromosome inactivation and imprinting in mammals. Nature Reviews Genetics 2005, 6:403-410.
188. Rhodes M.E., Li P.K., Burke A.M., Johnson D.A. Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition. Brain Research 1997, 773:28-32.
189. Robbins T.W., Roberts A.C. Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cerebral Cortex 2007, 17(Suppl. 1):i151-i160.
190. Robinson D.S., Sourkes T.L., Nies A., Harris L.S., Spector S., Bartlett D.L., Kaye I.S. Monoamine metabolism in human brain. Archives of General Psychiatry 1977, 34:89-92.
191. Robinson E.S., Eagle D.M., Mar A.C., Bari A., Banerjee G., Jiang X., et al. Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 2008, 33:1028-1037.
192. Ross J.L., Stefanatos G.A., Kushner H., Zinn A., Bondy C., Roeltgen D. Persistent cognitive deficits in adult women with Turner syndrome. Neurology 2002, 58:218-225.
193. Ross J.L., Zeger M.P., Kushner H., Zinn A.R., Roeltgen D.P. An extra X or Y chromosome: contrasting the cognitive and motor phenotypes in childhood in boys with 47,XYY syndrome or 47,XXY Klinefelter syndrome. Developmental Disabilities Research Reviews 2009, 15:309-317.
194. Ross M.T., Bentley D.R., Tyler-Smith C. The sequences of the human sex chromosomes. Current Opinion in Genetics and Development 2006, 16:213-218.
195. Roth M.E., Cosgrove K.P., Carroll M.E. Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Neuroscience and Biobehavioral Reviews 2004, 28:533-546.
196. Rovet J., Ireland L. Behavioral phenotype in children with Turner syndrome. Journal of Pediatric Psychology 1994, 19:779-790.
197. Rubia K., Hyde Z., Halari R., Giampietro V., Smith A. Effects of age and sex on developmental neural networks of visual-spatial attention allocation. Neuroimage 2010, 51:817-827.
198. Rucklidge J.J. Gender differences in attention-deficit/hyperactivity disorder. Pediatric Clinics of North America 2010, 33:357-373.
199. Rucklidge J.J., Tannock R. Neuropsychological profiles of adolescents with ADHD: effects of reading difficulties and gender. Journal of Child Psychology and Psychiatry and Allied Disciplines 2002, 43:988-1003.
200. Rupprecht R., Holsboer F. Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives. Trends in Neurosciences 1999, 22:410-416.
201. Russell H.F., Wallis D., Mazzocco M.M., Moshang T., Zackai E., Zinn A.R., et al. Increased prevalence of ADHD in Turner syndrome with no evidence of imprinting effects. Journal of Pediatric Psychology 2006, 31:945-955.
202. Ruud A., Arnesen P., Stray L.L., Vildalen S., Vesterhus P. Stimulant medication in 47,XYY syndrome: a report of two cases. Developmental Medicine and Child Neurology 2005, 47:559-562.
203. Sagvolden T., Aase H., Zeiner P., Berger D. Altered reinforcement mechanisms in attention-deficit/hyperactivity disorder. Behavioural Brain Research 1998, 94:61-71.
204. Sagvolden T., Russell V.A., Aase H., Johansen E.B., Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biological Psychiatry 2005, 57:1239-1247.
205. Sandoval V., Riddle E.L., Hanson G.R., Fleckenstein A.E. Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. Journal of Neuroscience 2002, 22:8705-8710.
206. Saudino K.J., Ronald A., Plomin R. The etiology of behavior problems in 7-year-old twins: substantial genetic influence and negligible shared environmental influence for parent ratings and ratings by same and different teachers. Journal of Abnormal Child Psychology 2005, 33:113-130.
207. Schaffner S.F. The X chromosome in population genetics. Nature Reviews Genetics 2004, 5:43-51.
208. Schneider H., Eisenberg D. Who receives a diagnosis of attention-deficit/hyperactivity disorder in the United States elementary school population?. Pediatrics 2006, 117:e601-e609.
209. Schubiner H. Substance abuse in patients with attention-deficit hyperactivity disorder: therapeutic implications. CNS Drugs 2005, 19:643-655.
210. Sekido R., Lovell-Badge R. Sex determination and SRY: down to a wink and a nudge?. Trends in Genetics 2009, 25:19-29.
211. Seo D., Patrick C.J., Kennealy P.J. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggression and Violent Behavior 2008, 13:383-395.
212. Shansky R.M., Glavis-Bloom C., Lerman D., McRae P., Benson C., Miller K., et al. Estrogen mediates sex differences in stress-induced prefrontal cortex dysfunction. Molecular Psychiatry 2004, 9:531-538.
213. Shapiro L.J., Mohandas T., Weiss R., Romeo G. Non-inactivation of an X-chromosome locus in man. Science 1979, 204:1224-1226.
214. Sharp S.I., McQuillin A., Gurling H.M. Genetics of attention-deficit hyperactivity disorder (ADHD). Neuropharmacology 2009, 57:590-600.
215. Shih J.C., Chen K., Ridd M.J. Monoamine oxidase: from genes to behavior. Annual Review of Neuroscience 1999, 22:197-217.
216. Silveri M.M., Rohan M.L., Pimentel P.J., Gruber S.A., Rosso I.M., Yurgelun-Todd D.A. Sex differences in the relationship between white matter microstructure and impulsivity in adolescents. Magnetic Resonance Imaging 2006, 24:833-841.
217. Simonoff E., Pickles A., Charman T., Chandler S., Loucas T., Baird G. Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. Journal of the American Academy of Child and Adolescent Psychiatry 2008, 47:921-929.
218. Sinclair A.H., Berta P., Palmer M.S., Hawkins J.R., Griffiths B.L., Smith M.J., et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 1990, 346:240-244.
219. Solanto M., Newcorn J., Vail L., Gilbert S., Ivanov I., Lara R. Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 2009, 19:663-671.
220. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behavioural Brain Research 1998, 94:127-152.
221. Specker S.M., Carlson G.A., Christenson G.A., Marcotte M. Impulse control disorders and attention deficit disorder in pathological gamblers. Annals of Clinical Psychiatry 1995, 7:175-179.
222. Stabellini R., de Mello J.C., Hernandes L.M., Pereira L.V. MAOA and GYG2 are submitted to X chromosome inactivation in human fibroblasts. Epigenetics 2009, 4:388-393.
223. Steel Z., Blaszczynski A. Impulsivity, personality disorders and pathological gambling severity. Addiction 1998, 93:895-905.
224. Stein M.A., Sarampote C.S., Waldman I.D., Robb A.S., Conlon C., Pearl P.L., et al. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics 2003, 112:e404.
225. Stergiakouli E., Langley K., Williams H., Walters J., Williams N.M., Suren S., et al. Steroid sulfatase is a potential modifier of cognition in Attention Deficit Hyperactivity Disorder. Genes, Brain, and Behavior 2011.
226. Stroop J.R. Studies of interference in serial verbal reactions. Journal of Experimental Psychology 1935, 18:643-661.
227. Strous R.D., Spivak B., Yoran-Hegesh R., Maayan R., Averbuch E., Kotler M., et al. Analysis of neurosteroid levels in attention deficit hyperactivity disorder. International Journal of Neuropsychopharmacology 2001, 4:259-264.
228. Sukhotina I.A., Dravolina O.A., Novitskaya Y., Zvartau E.E., Danysz W., Bespalov A.Y. Effects of mGlu1 receptor blockade on working memory, time estimation, and impulsivity in rats. Psychopharmacology (Berlin) 2008, 196:211-220.
229. Swanson J.M., Sergeant J.A., Taylor E., Sonuga-Barke E.J., Jensen P.S., Cantwell D.P. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998, 351:429-433.
230. Swerdlow N.R., Filion D., Geyer M.A., Braff D.L. "Normal" personality correlates of sensorimotor, cognitive, and visuospatial gating. Biological Psychiatry 1995, 37:286-299.
231. Tales A., Muir J.L., Bayer A., Snowden R.J. Spatial shifts in visual attention in normal ageing and dementia of the Alzheimer type. Neuropsychologia 2002, 40:2000-2012.
232. Tammimaki A.E., Mannisto P.T. Are genetic variants of COMT associated with addiction?. Pharmacogenetics and Genomics 2010, 20:717-741.
233. Tavares H., Zilberman M.L., Beites F.J., Gentil V. Gender differences in gambling progression. Journal of Gambling Studies 2001, 17:151-159.
234. Thapar A., Langley K., Owen M.J., O'Donovan M.C. Advances in genetic findings on attention deficit hyperactivity disorder. Psychological Medicine 2007, 37:1681-1692.
235. Thiel C.M., Zilles K., Fink G.R. Nicotine modulates reorienting of visuospatial attention and neural activity in human parietal cortex. Neuropsychopharmacology 2005, 30:810-820.
236. Thierry A.M., Gioanni Y., Degenetais E., Glowinski J. Hippocampo-prefrontal cortex pathway: anatomical and electrophysiological characteristics. Hippocampus 2000, 10:411-419.
237. Tranel D., Damasio H., Denburg N.L., Bechara A. Does gender play a role in functional asymmetry of ventromedial prefrontal cortex?. Brain 2005, 128:2872-2881.
238. Trent S., Dennehy A., Richardson H., Ojarikre O.A., Burgoyne P.S., Humby T., Davies W. Steroid sulfatase-deficient mice exhibit endophenotypes relevant to attention deficit hyperactivity disorder. Psychoneuroendocrinology 2011, doi:10.1016/j.psyneuen.2011.06.006 (Epub ahead of print).
239. Tripp G., Wickens J.R. Neurobiology of ADHD. Neuropharmacology 2009, 57:579-589.
240. Valera E.M., Brown A., Biederman J., Faraone S.V., Makris N., Monuteaux M.C., et al. Sex differences in the functional neuroanatomy of working memory in adults with ADHD. American Journal of Psychiatry 2010, 167:86-94.
241. van Boxtel M.P., ten Tusscher M.P., Metsemakers J.F., Willems B., Jolles J. Visual determinants of reduced performance on the Stroop color-word test in normal aging individuals. Journal of Clinical and Experimental Neuropsychology 2001, 23:620-627.
242. Van der Elst W., Van Boxtel M.P., Van Breukelen G.J., Jolles J. The Stroop color-word test: influence of age, sex, and education; and normative data for a large sample across the adult age range. Assessment 2006, 13:62-79.
243. van Gaalen M.M., Unger L., Jongen-Relo A.L., Schoemaker H., Gross G. Amphetamine decreases behavioral inhibition by stimulation of dopamine D2, but not D3, receptors. Behavioural Pharmacology 2009, 20:484-491.
244. Vawter M.P., Evans S., Choudary P., Tomita H., Meador-Woodruff J., Molnar M., et al. Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology 2004, 29:373-384.
245. Volkow N.D., Wang G.J., Fowler J.S., Gatley S.J., Logan J., Ding Y.S., et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. American Journal of Psychiatry 1998, 155:1325-1331.
246. Voytko M.L., Olton D.S., Richardson R.T., Gorman L.K., Tobin J.R., Price D.L. Basal forebrain lesions in monkeys disrupt attention but not learning and memory. Journal of Neuroscience 1994, 14:167-186.
247. Vuchinich R.E., Simpson C.A. Hyperbolic temporal discounting in social drinkers and problem drinkers. Experimental and Clinical Psychopharmacology 1998, 6:292-305.
248. Waddell J., McCarthy M.M. Sexual differentiation of the brain and ADHD: what is a sex difference in prevalence telling us?. Current Topics in Behavioral Neurosciences 2011, doi:10.1007\7854_2010_114 (Epub ahead of print).
249. Walderhaug E., Lunde H., Nordvik J.E., Landro N.I., Refsum H., Magnusson A. Lowering of serotonin by rapid tryptophan depletion increases impulsiveness in normal individuals. Psychopharmacology (Berlin) 2002, 164:385-391.
250. Wallis D., Russell H.F., Muenke M. Review: genetics of attention deficit/hyperactivity disorder. Journal of Pediatric Psychology 2008, 33:1085-1099.
251. Winstanley C.A., Baunez C., Theobald D.E., Robbins T.W. Lesions to the subthalamic nucleus decrease impulsive choice but impair autoshaping in rats: the importance of the basal ganglia in Pavlovian conditioning and impulse control. European Journal of Neuroscience 2005, 21:3107-3116.
252. Winstanley C.A., Eagle D.M., Robbins T.W. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clinical Psychology Review 2006, 26:379-395.
253. Winstanley C.A., Theobald D.E., Cardinal R.N., Robbins T.W. Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice. Journal of Neuroscience 2004, 24:4718-4722.
254. Wiskerke J., Schetters D., van Es I.E., van Mourik Y., den Hollander B.R., Schoffelmeer A.N., Pattij T. mu-Opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice. Journal of Neuroscience 2011, 31:262-272.
255. Wolf O.T., Kirschbaum C. Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Hormones and Behavior 2002, 41:259-266.
256. Wu J.B., Chen K., Li Y., Lau Y.F., Shih J.C. Regulation of monoamine oxidase A by the SRY gene on the Y chromosome. FASEB Journal 2009, 23:4029-4038.
257. Yen P.H., Marsh B., Allen E., Tsai S.P., Ellison J., Connolly L., et al. The human X-linked steroid sulfatase gene and a Y-encoded pseudogene: evidence for an inversion of the Y chromosome during primate evolution. Cell 1988, 55:1123-1135.
258. Zechner U., Wilda M., Kehrer-Sawatzki H., Vogel W., Fundele R., Hameister H. A high density of X-linked genes for general cognitive ability: a run-away process shaping human evolution?. Trends in Genetics 2001, 17:697-701.
259. Zheng P. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Progress in Neurobiology 2009, 89:134-152.
260. Zinn A.R., Roeltgen D., Stefanatos G., Ramos P., Elder F.F., Kushner H., et al. A Turner syndrome neurocognitive phenotype maps to Xp22.3. Behavioral and Brain Functions 2007, 3:24.
261. Zuloaga D.G., Puts D.A., Jordan C.L., Breedlove S.M. The role of androgen receptors in the masculinization of brain and behavior: what we've learned from the testicular feminization mutation. Hormones and Behavior 2008, 53:613-626.